The detailed information for PTAB case with proceeding number IPR2017-01054 filed by Fresenius Kabi USA, LLC against Hospira, Inc. et al. on Mar 8, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2017-01054
Filing Date
Mar 8, 2017
Petitioner
Fresenius Kabi USA, LLC
Respondent
Hospira, Inc. et al.
Status
Institution Denied
Respondent Application Number
13343672
Respondent Tech Center
1600
Respondent Patent Number
8242158
Institution Decision Date
Sep 6, 2017

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Sep 15, 2017PAPERBOARD

Refund Request

Sep 12, 2017PAPERPETITIONER

Trial Instituted Document

Sep 6, 2017PAPERBOARD

Patent Owner Preliminary Response

Jun 9, 2017PAPERPATENT OWNER

Notice of Accord Filing Date

Mar 23, 2017PAPERBOARD

Patent Owner Mandatory Notices

Mar 23, 2017PAPERPATENT OWNER

Patent Owner Power of Attorney

Mar 23, 2017PAPERPATENT OWNER

Power of Attorney

Mar 8, 2017PAPERPETITIONER

Petition for Inter Partes Review of US8242158

Mar 8, 2017PAPERPETITIONER

US8242158

Mar 8, 2017EXHIBITPETITIONER

US4544664

Mar 8, 2017EXHIBITPETITIONER

US4910214

Mar 8, 2017EXHIBITPETITIONER

US6716867

Mar 8, 2017EXHIBITPETITIONER

Precedex 2010 Label

Mar 8, 2017EXHIBITPETITIONER

Application No 13/343672

Mar 8, 2017EXHIBITPETITIONER

1999 Draft Labeling

Mar 8, 2017EXHIBITPETITIONER

Cain Declaration

Mar 8, 2017EXHIBITPETITIONER

Yaman Declaration

Mar 8, 2017EXHIBITPETITIONER

Office Action Feb. 13, 2012

Mar 8, 2017EXHIBITPETITIONER

Office Action Response, Mar. 13, 2012

Mar 8, 2017EXHIBITPETITIONER

Lavoisier

Mar 8, 2017EXHIBITPETITIONER

Rappaport Memorandum

Mar 8, 2017EXHIBITPETITIONER

Dyck

Mar 8, 2017EXHIBITPETITIONER

Scheinin

Mar 8, 2017EXHIBITPETITIONER

Yuen

Mar 8, 2017EXHIBITPETITIONER

Venn

Mar 8, 2017EXHIBITPETITIONER

Avis

Mar 8, 2017EXHIBITPETITIONER

Webb

Mar 8, 2017EXHIBITPETITIONER

Ponder

Mar 8, 2017EXHIBITPETITIONER

Interview Summary, Feb. 28, 2012

Mar 8, 2017EXHIBITPETITIONER

McCormick Memorandum

Mar 8, 2017EXHIBITPETITIONER

Notice of Allowance, Apr. 18, 2012

Mar 8, 2017EXHIBITPETITIONER

Giorgi

Mar 8, 2017EXHIBITPETITIONER

Eichhorn

Mar 8, 2017EXHIBITPETITIONER

Palmgren

Mar 8, 2017EXHIBITPETITIONER

Gerlach

Mar 8, 2017EXHIBITPETITIONER

Jenkins

Mar 8, 2017EXHIBITPETITIONER

Wang

Mar 8, 2017EXHIBITPETITIONER

Remington

Mar 8, 2017EXHIBITPETITIONER

INTENTIONALLY LEFT BLANK

Mar 8, 2017EXHIBITPETITIONER

Pacheco

Mar 8, 2017EXHIBITPETITIONER

Liu

Mar 8, 2017EXHIBITPETITIONER

Linden

Mar 8, 2017EXHIBITPETITIONER

Cain

Mar 8, 2017EXHIBITPETITIONER

Hospira 10Q June 2015

Mar 8, 2017EXHIBITPETITIONER

Anderson

Mar 8, 2017EXHIBITPETITIONER

FDA, Precedex Orange Book

Mar 8, 2017EXHIBITPETITIONER

Merry

Mar 8, 2017EXHIBITPETITIONER

Desai

Mar 8, 2017EXHIBITPETITIONER

DiSilvio

Mar 8, 2017EXHIBITPETITIONER

Neu

Mar 8, 2017EXHIBITPETITIONER

Potts

Mar 8, 2017EXHIBITPETITIONER

Rodriguez-Gonzalez

Mar 8, 2017EXHIBITPETITIONER

WHO Glossary - Injectable Medicines

Mar 8, 2017EXHIBITPETITIONER

Chrysostomou

Mar 8, 2017EXHIBITPETITIONER

Certification of Word Count

Mar 8, 2017PAPERPETITIONER

Motion to Join

Mar 8, 2017PAPERPETITIONER